Liver News and Research

RSS

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Illinois bill that allows people with HIV to donate organs to other people who are HIV-positive

The bill was written by state representative Larry McKeon, who has HIV, and signed by Governor Rod R. Blagojevich. In the past, people with HIV were not considered good candidates for transplantation because of a reduced life expectancy. Drug treatments are now more advanced, and people with HIV are living longer.

21 Jul 2004

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Roche announced today the submission of a supplemental new biologics license application (sBLA) with the U.S. Food and Drug Administration to market Pegasys(R) (peginterferon alfa-2a) for the treatment of chronic hepatitis B (CHB).

21 Jul 2004

Debate over acetaminophen and acute liver failure

One expert questions the acceptability of the current level of acetaminophen-related injury and death, while another suggests that acetaminophen overdoses are misunderstood.

20 Jul 2004

Blacks receive transplants at disproportionately low rates

Black people in the United States have reduced access to many medical therapies and liver transplantation is one area where such disparity is suspected to exist.

15 Jul 2004

Research provides new insight into the carefully controlled architectural changes that underlie organ development

A new research study demonstrates that a single chemical growth factor orchestrates a complex developmental process by sequentially activating distinct subsets of molecular signals.

13 Jul 2004

Hospitals are being urged to address the alcohol problems that afflict up to 30 per cent of men and 15 per cent of women

Hospitals are being urged to address the alcohol problems that afflict up to 30 per cent of men and 15 per cent of women who attend as in-patients or in accident and emergency.

10 Jul 2004

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Research into the action of a key cancer gene has serendipitously uncovered its vital role in nerve growth, Cancer Research UK scientists reveal in a paper published on Wednesday.

8 Jul 2004

Researchers found that a significant number of men get the hepatitis B virus behind bars

In the first study to gauge the risks of contracting HIV and hepatitis in Rhode Island prisons, Brown University researchers found that a significant number of men get the hepatitis B virus behind bars – a finding that led the team to call for prison-wide vaccinations. Results are published in the current edition of the American Journal of Public Health.

7 Jul 2004

Liver News and Research

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Bladder-sparing treatment shows promise against cancer

Illinois bill that allows people with HIV to donate organs to other people who are HIV-positive

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Debate over acetaminophen and acute liver failure

Blacks receive transplants at disproportionately low rates

Research provides new insight into the carefully controlled architectural changes that underlie organ development

Hospitals are being urged to address the alcohol problems that afflict up to 30 per cent of men and 15 per cent of women

Understanding the role of c-Jun in repairing damaged nerve cells could help treat spinal injuries and increase our understanding of cancer

Researchers found that a significant number of men get the hepatitis B virus behind bars

New minimally invasive surgery - flexible transgastric peritoneoscopy, or FTP

Renowned Chinese surgeon who revealed the SARS cover-up last year is reported to be undergoing brainwashing

Rabies infections in organ donor and transplant recipients

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

New educational campaign on celiac disease

Opuntia ficus indica, a type of prickly pear cactus reduces hangover symptoms

The EU is contributing €9 million to the “Vigilance against Viral Resistance” (VIRGIL) project

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News